Xu Yizhen, Osborne Brent W, Stanton Robert C
Renal Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
Am J Physiol Renal Physiol. 2005 Nov;289(5):F1040-7. doi: 10.1152/ajprenal.00076.2005. Epub 2005 Jun 14.
The incidence of diabetic nephropathy has been increasing. Studies have shown that oxidative stress (due to increased oxidant production and/or decreased antioxidant activity) is a critical underlying mechanism. The principal intracellular reductant is NADPH whose production is mainly dependent on glucose-6-phosphate dehydrogenase (G6PD) activity. Our work in cultured cells previously showed that high glucose caused activation of protein kinase A (PKA) and subsequent phosphorylation and inhibition of G6PD activity and hence decreased NADPH (Zhang Z, Apse K, Pang J, and Stanton RC. J Biol Chem 275:40042-40047, 2000). The purpose of this study was to determine whether these findings occur in diabetic rats (induced by streptozotocin) compared with control. G6PD activity and accordingly NADPH levels and glutathione levels were significantly decreased in diabetic kidneys compared with control kidneys. Lipid peroxidation was significantly increased, which correlated with decreased G6PD activity (r = 0.48). G6PD expression was significantly reduced, which correlated with decreased G6PD activity (r = 0.72). PKA activity and serine phosphorylation of G6PD were significantly increased and were closely correlated with decreased G6PD activity (r = 0.51 for PKA activity; r = 0.93 for serine phosphorylation of G6PD). Insulin treatment and/or correction of hyperglycemia ameliorated the changes caused by diabetes. In conclusion, chronic hyperglycemia caused inhibition of G6PD activity via decreased expression and increased phosphorylation of G6PD, which therefore led to increased oxidative stress.
糖尿病肾病的发病率一直在上升。研究表明,氧化应激(由于氧化剂产生增加和/或抗氧化活性降低)是一个关键的潜在机制。主要的细胞内还原剂是NADPH,其产生主要依赖于葡萄糖-6-磷酸脱氢酶(G6PD)的活性。我们之前在培养细胞中的研究表明,高糖会导致蛋白激酶A(PKA)活化,随后使G6PD活性发生磷酸化并受到抑制,从而导致NADPH减少(Zhang Z, Apse K, Pang J, and Stanton RC. J Biol Chem 275:40042 - 40047, 2000)。本研究的目的是确定与对照组相比,这些发现是否在链脲佐菌素诱导的糖尿病大鼠中出现。与对照肾脏相比,糖尿病肾脏中的G6PD活性以及相应的NADPH水平和谷胱甘肽水平显著降低。脂质过氧化显著增加,这与G6PD活性降低相关(r = 0.48)。G6PD表达显著降低,这与G6PD活性降低相关(r = 0.72)。PKA活性和G6PD的丝氨酸磷酸化显著增加,并且与G6PD活性降低密切相关(PKA活性的r = 0.51;G6PD丝氨酸磷酸化的r = 0.93)。胰岛素治疗和/或纠正高血糖改善了糖尿病引起的变化。总之,慢性高血糖通过降低G6PD表达和增加G6PD磷酸化导致G6PD活性受到抑制,进而导致氧化应激增加。